Sol-Gel Technologies Ltd. (SLGL) Stock

Sol-Gel Technologies Ltd. (SLGL) is a Healthcare stock trading at $72.94 (as of 2026-06-18), with a market capitalization of $205.76M and a trailing P/E of -33.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Sol-Gel Technologies is a clinical-stage pharmaceutical company developing topical dermatology products that use its microencapsulation-based drug delivery platform. Its pipeline includes late-stage candidates for acne vulgaris and papulopustular rosacea, earlier-stage programs, and also development of generic topical dermatology products, with collaboration involvement from Perrigo.

Valuation — source: SEC EDGAR (first-party)
Price$72.94
Market Cap$205.76M
P/E Ratio-33.7
EV / EBITDA-26.1
Price / Book9.02
Price / Sales10.61
DCF Value (model)$6.07
DCF Upside vs Price-91.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$19.39M
Net Margin-31.6%
Return on Equity-26.9%
Current Ratio4.37
Revenue Growth (YoY)68.0%
EPS Growth (YoY)476.3%
FCF Growth (YoY)-102.0%
Financial Health — source: SEC EDGAR
Altman Z-Score6.72 (safe)
Valuation vs Sector & Industry
Stock P/E-33.7
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-261.5%
vs Industry-298.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderOpaleye Management Inc. ($39.61M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOMoshe Arkin
Employees34
CountryIL
IPO Date2018-02-01

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Dogwood Therapeutics, Inc. (DWTX)
  • Coya Therapeutics, Inc. (COYA)
  • BioHarvest Sciences Inc. Common Stock (BHST)
  • Inovio Pharmaceuticals, Inc. (INO)
  • Cognition Therapeutics, Inc. (CGTX)
  • Spruce Biosciences, Inc. (SPRB)
  • Fortress Biotech, Inc. (FBIO)
  • Eledon Pharmaceuticals, Inc. (ELDN)
SLGL earnings history · SLGL institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.